[1] Boag JW. The statistical treatment of cell survival data//Alper T. Cell survival after low doses of radiation: theoretical and clinical implications. London: John wiley & sons,1975:40-53. [2] Spadinger I,Poon SS,Palcic B. Automated detection and recognition of live cells in tissue culture using image cytometry. Cytometry,1989,10:375-381. [3] Durand RE. Use of a cell sorter for assays of cell clonogenicity. Cancer Res,1986,46:2775-2778. [4] Marples B,Joiner MC. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiat Res,1993,133:41-51. [5] Marples B,Adomat H,Koch CJ,et al. Response of V79 cells to low doses of X-rays and negative pi-mesons: clonogenic survival and DNA strand breaks. Int J Radiat Biol,1996,70:429-436. [6] Wouters BG,Sy AM,Skarsgard LD. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiat Res,1996,146:399-413. [7] Wouters BG,Skarsgard LD. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity. Radiat Res,1994,138:76-80. [8] Vral A,Louagie H,Thierens H,et al. Micronucleus frequencies in cytokinesis-blocked human B lymphocytes after low dose gamma-irradiation. Int J Radiat Biol,1998,73:549-555. [9] Tsoulou E,Baggio L,Cherubini R,et al. Low-dose hypersensitivity of V79 cells under exposure to gamma-rays and 4 HE ions of different energies: survival and chromosome aberrations. Int J Radiat Biol,2001,77:1133-1139. [10] Dionet C,Tchirkov A,Alard JP,et al. Effects of low-dose neutrons applied at reduced dose rate on human melanoma cells. Radiat Res,2000,154:406-411. [11] Redpath JL,Lu Q,Lao X,et al. Low doses of diagnostic energy X-rays protect against neoplastic transformation in vitro. Int J Radiat Biol,2003,79:235-240. [12] Redpath JL,Short SC,Woodcock M,et al. Low-dose reduction in transformation frequency compared with unirradiated controls: the role of hyper-radiosensitivity to cell death. Radiat Res,2003,159:433-436. [13] Short SC,Kelly J,Maryes CR,et al. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. Int J Radiat Biol,2001,77:655-664. [14] Hamilton CS,Denham JW,O′Brien M,et al. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol,1996,40:23-30. [15] Harney J,Shah N,Short S,et al. The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiother Oncol,2004,70:319-329. [16] Harney J,Short SC,Shah N,et al. Low dose hyper-radiosensitivity in metastatic tumors. Int J Radiat Oncol Biol Phys,2004,59:1190-1195. [17] Paulson JR,Taylor SS. Phosphorylation of histone 1 and 3 and nonhistone high mobility group 14 by an endogenous kinase in Hela metaphase chromosomes. J Biol Chem,1982,257:6064-6072. [18] Ajiro K,Nishimoto T. Specific site of histone H3 phosphorylation related to the maintenance of premature chromosome condensation. evidence for catalytically induced interchange of the subunits. J Biol Chem,1985,260:15379-15381. [19] Xu B,Kim S,Kastan MB. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol Cell Biol,2001,21:3445-3450. [20] Xu B,Kim ST,Lim DS,et al. Two molecularly distinct G2/M checkpoints are induced by ionizing irradiation. Mol Cell Biol,2002,22:1049-1059. [21] Kremepler A,Deckbar D,Jeggo PA,et al. An imperfect G2/M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cells. Cell Cycle,2007,6:1682-1686. [22] Landsverk KS,Patzke S,Rein ID,et al. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle,2011,10:819-829. [23] Short SC,Woodcock M,Marples B,et al. The effects of cell cycle phase on low dose hyper-radiosensitivity. Int J Radiat Biol,2003,79:99-105. [24] Marples B,Wouters BG,Joiner MC. An association between the radiation-induced arrest of G2 phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism? Radiat Res,2003,160:38-45. [25] Krueger SA,Collis SJ,Joiner MC,et al. The transition in survival from low-dose hyper-radiosensitivity to incressed radioresisitance is independent of activation of ATM SER1981 activity. Int J Radiat Oncol Biol Phys,2007,69:1262-1271. [26] Krueger SA,Wilson GD,Piasentin E,et al. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int J Radiat Oncol Biol Phys,2010,77:1509-1517. [27] Xue L,Yu D,Furusawa Y,et al. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions. Int J Radiat Oncol Biol Phys,2009,75:235-243. [28] Fernet M,Chanet FM,Hall J,et al. Control of the G2/M checkpoints after exposure to low doses of ionizing radiation: implication for hyper-radiosensitivity. DNA Repair,2010,9:48-57. [29] O′Driscoll M,Jeggo PA. The role of double-strand break repair-insights from human genetics. Nat Rev Gent,2006,7:45-54. [30] Marples B,Joiner MC. Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased radioresistance. Int J Radiat Biol,2000,76:305-312. [31] Skov KA. Radioresponsiveness at low doses: hyper-radiosensitivity and increased radioresistance in mammalian cells. Mutat Res,1999,430:241-253. [32] Terzoudi GI,Manola KN,Pantelias GE,et al. Checkpoint abrogation in G2 compromises repair of chromosoma breaks in ataxia telangiectasia cells. Cancer Res,2005,65:11292-11296. [33] Enns L,Bogen KT,Wizniak J,et al. Low-dose radiation hyper-sensitivity is associated with p53-dependent apoptosis. Mol Cancer Res,2004,2:557-566. [34] Krueger SA,Joiner MC,Weinfels M,et al. Role of apoptosis in low-dose hyper-radiosensitivity. Radiat Res,2007,167:260-267. [35] Arnold SM,Regine WF,Ahmed MM,et al. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Oncol Biol Phys,2004,58:1411-1417. [36] Regine WF,Hanna N,Garofalo MC,et al. Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase Ⅰ study exploring a new treatment paradigm. Int J Radiat Oncol Biol Phys,2007,68:172-177. [37] Valentini V,Massaccesi M,Balducci M,et al. Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? Int J Radiat Oncol Biol Phys,2010,76:535-539.
2012, Vol. 21 
